Therapeutic potential of resveratrol in the treatment of glioma: Insights into its regulatory mechanisms

Ehsan Dadgostar, Maryam Fallah, Fatemeh Izadfar, Reza Heidari-Soureshjani, Michael Aschner, Omid Reza Tamtaji, Hamed Mirzaei

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Glioma is a prevalent primary tumor of the brain and spinal cord. Several biological path¬ways play an important role in the pathogenesis of glioma, including apoptosis, autophagy, cell cycle arrest, migration, and invasion. The low efficacy of chemotherapy and radiation therapy has forced researchers to evaluate alternative treatments for glioma. In this regard, flavonoids have been studied. Resveratrol is a flavonoid with distinct pharmacological activities that has been used in the treatment of various diseases. Several recent studies have also focused on its therapeutic efficacy against glio¬ma. Resveratrol exerts its pharmacological attributes by regulating various molecular and cellular pathways. Here, we review contemporary knowledge in support of the use of resveratrol in the treat¬ment of glioma and its effects on various molecular and cellular mechanisms.

Original languageEnglish (US)
Pages (from-to)2835-2847
Number of pages13
JournalMini-Reviews in Medicinal Chemistry
Issue number18
StatePublished - Nov 2021


  • Apoptosis
  • Autophagy
  • Cell cycle arrest
  • Glioma
  • Metastasis
  • Resveratrol

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Cancer Research


Dive into the research topics of 'Therapeutic potential of resveratrol in the treatment of glioma: Insights into its regulatory mechanisms'. Together they form a unique fingerprint.

Cite this